Biotech Value Creation (Podcast Syneos Health / Treehill Partners)

Biotech Value Creation (Podcast Syneos Health / Treehill Partners)

The game continues to change in biotech as continued macroeconomic uncertainty has far reaching implications for the future of the biopharma ecosystem. Biotechs can no longer operate toward the single goal of being acquired by, or of licensing their assets to, large pharma—and players may need to develop products further than in the past, and therefore strategic pathway optionality needs to be weaved into and maintained throughout product and corporate development.

But with a multitude of new challenges facing this industry come multifold new opportunities for value creation and chances to reach new heights.

Listen to this podcast to learn strategic and operational implications for the biotech C-suite and share perspectives on how companies can succeed in an increasingly competitive environment.

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.

Link to Podcast | Biotech Value Creation | Syneos Health Website

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.